Part of DVT events is explained by a strong genetic component that includes the deficiencies of natural anticoagulants proteins (antithrombin, protein C and protein S), factor V Leiden (FVL), prothrombin G20210A mutation, fibrinogen gamma chain C10034T mutation [2]. The gene discussed is F2; the disease is deep vein thrombosis.